Literature DB >> 7488605

Effects of interferon alfa and gamma on human uveal melanoma cells in vitro.

I de Waard-Siebinga1, W M Creyghton, J Kool, M J Jager.   

Abstract

BACKGROUND: Uveal melanoma is a tumour with a high incidence of metastasis and a high mortality rate. Additional therapies to obtain a better local control or an effective treatment of metastases are necessary. Interferons may be applied.
METHODS: The effects of human interferon alfa and gamma on proliferation and expression of immunologically important molecules of human uveal melanoma cells in vitro were studied. A propidium iodide assay was used to determine proliferation and immunostaining with monoclonal antibodies was applied to detect changes in antigen expression on two primary uveal melanoma cell lines, Mel 202 and 92-1.
RESULTS: Interferon alfa inhibited proliferation of cell line 92-1 at a concentration of 50 IU/ml, but had no effect on cell line Mel 202, while interferon gamma inhibited growth of both cell lines. Only interferon gamma had a visible effect on cell morphology. With respect to the immunomodulatory effects, interferon alfa increased monomorphic HLA class I expression, but did not affect HLA class II expression. Interferon gamma induced not only HLA class I but also class II expression. The effects on HLA expression were locus-specific with the strongest effects observed for HLA-B and DR products. Small differences were observed with respect to the susceptibility of two different melanoma cell lines to antiproliferative effects and to modulation of antigen expression.
CONCLUSION: The effects of interferon alfa and gamma on human uveal melanoma cells in vitro suggest a potential role of these cytokines in the treatment of patients with uveal melanoma. In particular, the immunomodulatory effects of these cytokines in vitro imply that treatment of patients with these cytokines might stimulate a beneficial antimelanoma immune response in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488605      PMCID: PMC505272          DOI: 10.1136/bjo.79.9.847

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  39 in total

1.  Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon gamma.

Authors:  A Anichini; R Mortarini; G Fossati; G Parmiani
Journal:  Int J Cancer       Date:  1986-10-15       Impact factor: 7.396

2.  Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons.

Authors:  P Giacomini; R Gambari; R Barbieri; P Nisticò; R Tecce; S Pestka; K Gustafsson; P G Natali; P B Fisher
Journal:  Anticancer Res       Date:  1986 Sep-Oct       Impact factor: 2.480

Review 3.  Interferon therapy in cancer: from imaginon to interferon.

Authors:  D Goldstein; J Laszlo
Journal:  Cancer Res       Date:  1986-09       Impact factor: 12.701

4.  Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon-alfa2b.

Authors:  H M Golomb; A Fefer; D W Golde; H Ozer; C Portlock; R Silber; J Rappeport; M J Ratain; J Thompson; E Bonnem
Journal:  Semin Oncol       Date:  1988-10       Impact factor: 4.929

5.  Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.

Authors:  D Taramelli; G Fossati; A Mazzocchi; D Delia; S Ferrone; G Parmiani
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

6.  A phase II trial of intermittent leukocyte interferon and high dose chlorambucil in the treatment of non-Hodgkin's lymphoma resistant to conventional therapy.

Authors:  R H Clark; N V Dimitrov; J A Axelson; L J Charamella; P B Stott
Journal:  Am J Clin Oncol       Date:  1989-02       Impact factor: 2.339

7.  Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products.

Authors:  N J Stam; H Spits; H L Ploegh
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

8.  Effect of recombinant monokines, lymphokines, and other agents on clonal proliferation of human lung cancer cell lines.

Authors:  M Munker; R Munker; R E Saxton; H P Koeffler
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

Review 9.  Effects of interferon on differentiation of normal and tumor cells.

Authors:  P B Fisher; S Grant
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

10.  Recombinant human IFN-gamma, but not IFN-alpha or IFN-beta, enhances MHC- and non-MHC-encoded glycoproteins by a protein synthesis-dependent mechanism.

Authors:  P Giacomini; R Tecce; R Gambari; A Sacchi; P B Fisher; P G Natali
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

View more
  8 in total

1.  Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

Authors:  K Norose; A Yano
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

2.  Field production and functional evaluation of chloroplast-derived interferon-alpha2b.

Authors:  Philip A Arlen; Regina Falconer; Sri Cherukumilli; Amy Cole; Alexander M Cole; Karen K Oishi; Henry Daniell
Journal:  Plant Biotechnol J       Date:  2007-05-09       Impact factor: 9.803

3.  The relation between c-myc expression and interferon sensitivity in uveal melanoma.

Authors:  P N Tulley; M Neale; D Jackson; J S Chana; R Grover; I Cree; A O Grobbelaar; G D Wilson
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

4.  Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes.

Authors:  T Huibertus van Essen; Sake I van Pelt; Inge H G Bronkhorst; Mieke Versluis; Fariba Némati; Cécile Laurent; Gregorius P M Luyten; Thorbald van Hall; Peter J van den Elsen; Pieter A van der Velden; Didier Decaudin; Martine J Jager
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

5.  Interferon Signaling Is Frequently Downregulated in Melanoma.

Authors:  Sara Alavi; Ashleigh Jacqueline Stewart; Richard F Kefford; Su Yin Lim; Elena Shklovskaya; Helen Rizos
Journal:  Front Immunol       Date:  2018-06-21       Impact factor: 7.561

Review 6.  HLA Expression in Uveal Melanoma: An Indicator of Malignancy and a Modifiable Immunological Target.

Authors:  Zahra Souri; Annemijn P A Wierenga; Arend Mulder; Aart G Jochemsen; Martine J Jager
Journal:  Cancers (Basel)       Date:  2019-08-07       Impact factor: 6.639

7.  A Novel Four Genes of Prognostic Signature for Uveal Melanoma.

Authors:  Yan Liu; Huibin Du; Qi Wan; Yan He; Wei Lu; Wenhao Wang; Xiaohui Lv
Journal:  J Oncol       Date:  2022-04-05       Impact factor: 4.375

8.  Influence of CD8+ T regulatory cells on intraocular tumor development.

Authors:  Kyle C McKenna; Dana M Previte
Journal:  Front Immunol       Date:  2012-09-28       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.